Skip to content

Depression: all studies

Page 915 of 1,034: studies 9,141 to 9,150 of 10,336, newest first. Back to the depression overview

Research

The occurrence and predictive factors of sleep paralysis in university students

Neuropsychiatric Disease and Treatment November 14, 2016 M. Líšková, Denisa Janečková, Lucie Klůzová Kráčmarová et al.

The aim of the present study was to assess the occurrence and predictive factors of sleep paralysis (SP) in Czech university students. Our sample included 606 students who had experienced at least one episode of SP. The participants completed an online battery of questionnaires involving questionnaires focused on describing their sleep habits and SP episodes, the 18-item Boundary Questionnaire...

Mind and Body Training to Improve Functioning and Coping With Chronic Pain: A Pilot Study

Journal of Patient-Centered Research and Reviews November 11, 2016 Olga Valieva, Leah M Welsh, Betty J. Amuzu et al.

Background: Patients with chronic pain are often crippled by psychological distress, depression and fear. These patients also can develop altered pain perception, with enhanced brain activity in pain-responsive regions and those associated with anxiety/depression. Exercise and meditation can impact pain-reducing brain areas and positively influence pain characteristics. Purpose: To alter pain...

Prevalence, patterns, and predictors of meditation use among US adults: A nationally representative survey.

Scientific Reports November 10, 2016 Holger Cramer, Helen Hall, Matthew Leach et al.

Emerging evidence suggests substantial health benefits from using meditation. While there are some indications that the popularity of meditation is increasing, little is known about the prevalence, patterns, and predictors of meditation use in the general population. In this secondary analysis of data from the 2012 US National Health Interview Survey (NHIS) (n = 34,525), lifetime and 12-month...

Potential Psychiatric Uses for MDMA

Clinical Pharmacology & Therapeutics November 10, 2016 Bb Yazar‐klosinski, Mc Mithoefer 81 citations

Phase II trials of 3,4‐methylenedioxymethamphetamine (MDMA)‐assisted psychotherapy have demonstrated initial safety and efficacy for treatment of posttraumatic stress disorder (PTSD), with potential for expansion to depression and anxiety disorders. In these trials, single doses of MDMA are administered in a model of medication‐assisted psychotherapy, differing from trials involving daily drug...

DOI: 10.1002/cpt.565 (opens in new tab) MDMA-Assisted Psychotherapy PTSD Treatment Mental health innovation Regulatory pathways

Mindfulness-based cognitive therapy for depressed individuals improves suppression of irrelevant mental-sets

European Archives of Psychiatry and Clinical Neuroscience November 9, 2016 Jonathan Greenberg, Benjamin G. Shapero, David Mischoulon et al. 17 citations

An impaired ability to suppress currently irrelevant mental-sets is a key cognitive deficit in depression. Mindfulness-based cognitive therapy (MBCT) was specifically designed to help depressed individuals avoid getting caught in such irrelevant mental-sets. In the current study, a group assigned to MBCT plus treatment-as-usual (n = 22) exhibited significantly lower depression scores and...

DOI: 10.1007/s00406-016-0746-x (opens in new tab) Full text (opens in new tab) Mindfulness-based cognitive therapy Cognition Depression economics Clinical psychology +3

'I've Changed My Mind', Mindfulness-Based Childbirth and Parenting (MBCP) for pregnant women with a high level of fear of childbirth and their partners: study protocol of the quasi-experimental controlled trial.

BMC Psychiatry November 7, 2016 Irena K Veringa, Esther I. de Bruin, Nancy Bardacke et al.

Background: Approximately 25 % of pregnant women suffer from a high level of Fear of Childbirth (FoC), as assessed by the Wijma Delivery Expectancy Questionnaire (W-DEQ-A, score ≥66). FoC negatively affects pregnant women's mental health and adaptation to the perinatal period. Mindfulness-Based Childbirth and Parenting (MBCP) seems to be potentially effective in decreasing pregnancy-related...

Psychedelics as Medicines: An Emerging New Paradigm

Clinical Pharmacology & Therapeutics November 4, 2016 De Nichols, Mw Johnson, Cd Nichols 366 citations

Scientific interest in serotonergic psychedelics (e.g., psilocybin and LSD; 5‐HT 2A receptor agonists) has dramatically increased within the last decade. Clinical studies administering psychedelics with psychotherapy have shown preliminary evidence of robust efficacy in treating anxiety and depression, as well as addiction to tobacco and alcohol. Moreover, recent research has suggested that...

Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.

Progress in Neuro-Psychopharmacology and Biological Psychiatry November 3, 2016 Kristian Gaarn Du Jardin, Heidi Kaastrup Müller, Betina Elfving et al.

A single i.v. infusion of ketamine, classified as an N-methyl-d-aspartate (NMDA) receptor antagonist, may alleviate depressive symptoms within hours of administration in treatment resistant depressed patients, and the antidepressant effect may last for several weeks. These unique therapeutic properties have prompted researchers to explore the mechanisms mediating the antidepressant effects of...

N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice.

Progress in Neuro-Psychopharmacology and Biological Psychiatry November 3, 2016 Jen-Cheng Lin, Ming‐huan Chan, Mei-Yi Lee et al.

Ketamine, a dissociative anesthetic, produces rapid and sustained antidepressant effects at subanesthtic doses. However, it still inevitably induces psychotomimetic side effects. N,N-dimethylglycine (DMG) is a derivative of the amino acid glycine and is used as a dietary supplement. Recently, DMG has been found acting at glycine binding site of the N-methyl-d-aspartate receptor (NMDAR). As...

DOI: 10.1016/j.pnpbp.2016.06.002 (opens in new tab) Full text (opens in new tab) Anesthesia Forced swimming Glycine Nmda receptor +1

Ketamine: NMDA Receptors and Beyond

Journal of Neuroscience November 2, 2016 Charles F Zorumski, Yukitoshi Izumi, Steven Mennerick 252 citations

Human studies examining the effects of the dissociative anesthetic ketamine as a model for psychosis and as a rapidly acting antidepressant have spurred great interest in understanding ketamine's actions at molecular, cellular, and network levels. Although ketamine has unequivocal uncompetitive inhibitory effects on N-methyl-d-aspartate receptors (NMDARs) and may preferentially alter the...